NEOGENOMICS INC — Director's Dealing 2018

May 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-05-25

Reporting Person: SHOVLIN ROBERT J. (President, Clinical Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-25	Common Stock	M	16666	—	Acquired	23216	Direct
2018-05-25	Common Stock	F	3725	$11.57	Disposed	19491	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-25	Restricted Stock	$0.0	M	16666	Disposed		Common Stock (16666.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$8.03	2023-02-26	Common Stock (288500.0)	288500	Direct
Stock Option (Right to Buy)	$4.79	2019-10-13	Common Stock (300000.0)	300000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000.0)	200000	Direct

Footnotes

F1: Shares withheld by NeoGenomics Laboratories, Inc. to satisfy the tax obligations in connection with the May 25, 2018 vesting of restricted stock.

F2: Each share of restricted stock represents the contingent right to receive one share of common stock upon vesting of the unit.

F3: Restricted stock will vest as follows; 16,666 vested on May 25, 2018 and 16,667 will vest on May 25, 2019 and 2020.

F4: These restricted stock will terminate upon the earliest of death, termination of employment or the last vesting date.

F5: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F6: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F7: On October 13, 2014, Mr. Shovlin was granted an option to purchase 300,000 shares. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis.

F8: On April 20, 2016, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.